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Background Findings Discussion
With 47,600 opioid overdose related deaths in the U.S. in 2017, the 
opioid crisis is of national concern.1 Cesarean delivery is the most 
common surgery worldwide, with over 1.2 million in the U.S. in 2018 
alone.2,3 As cesarean delivery is a highly prevalent surgery it has a 
large capacity to influence the opioid epidemic. Literature is showing 
that Enhanced Recovery after Surgery (ERAS) and multimodal 
analgesia are effective means of managing postoperative pain while 
minimizing opioid use.4,5,6,7,8 This project aims to help discover if 
introduction of ERAS, and more specifically it’s multimodal analgesia 
aspect, has helped decrease oral morphine milligram equivalent 
(MME) consumption of opioids following cesarean delivery.
Table 1: Patient Characteristics  (N=978) Figure 1: Cumulative Median Oral MME
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Methods
• Design: Retrospective Observational Cohort Study
• Human Subjects Protection: Data fully de-identified and stored 
only in a secure REDCap database; patient care was not altered 
• Inclusion Criteria: Adult women undergoing scheduled cesarean 
delivery at Providence Sacred Heart Medical Center, Spokane, WA
• Exclusion Criteria: Urgent/emergent cesarean delivery, use of an 
intravenous opioid patient-controlled analgesia (PCA) device
• Measured Outcome: Cumulative 72-hr oral MME consumption 
following cesarean delivery
• Baseline Comparability Demographics: Age, ASA, BMI, 
gravida/parity, weeks gestation, prior cesarean delivery, multiple 
birth, estimated blood loss, etc. (table 1)
• Statistical Analysis: 
• A Priori Power Analysis: n=670 (n=335 per group) participants 
for adequate power (α=0.5, β=0.2)
• Bivariate Analysis: Independent Samples T-Test (symmetrical 
data) and Mann Whitney U Test (skewed data)
• Multivariate Analysis: An interrupted time series was 
conducted for comparison of oral median MME over time
• Split File Analysis conduced to confirm accuracy of findings
The implementation of ERAS and use of multimodal analgesia led 
to a sustained MME decrease among women utilizing opioids post 
scheduled cesarean delivery.
The pre-implementation group (n=464) utilized a median of 90 
[IQR 37.5-165] oral MME while the post-implementation group 
(n=514) used 71.3 [IQR 30-127.5] median oral MME (p<0.01). 
This was a difference of 18.7 oral MME, or a 21% reduction.
The use of multimodal analgesia following scheduled cesarean 
delivery is an effective means of managing postoperative pain 
while also reducing the need for opioids.
Table 2: Median Oral MME (N=978)
Figure 2: Interrupted Time Series: Cumulative 72-Hour Median 
Oral MME





24 hr 37.5 [15-67.5] 26.3 [12-49] p<0.01
48 hr 45 [22.5-82.5] 37.5 [15-64] p<0.01
72 hr 90 [37.5-165] 71.3 [30-127.5] p<0.01
24-48 hrs 60 [30-86.8] 41.3 [22.5-75] p<0.01
48-72 hrs 30 [15-67.5] 15 [7.5-52.5] p=0.02
24-72 hrs 45 [15-82.5] 37.5 [15-60] p<0.01






Age 31.1 (± 5.3) 31.1 (± 5.5) p=0.98
BMI 32.9 [28.7-38.2] 33 [29.3-38.3] p=0.39
Gestational Age (Weeks) 39 (± 2.2) 39 (± 1.7) p=0.50
1 Min APGAR Score 8 (± 1) 8 (± 1) p=0.95
5 Min APGAR Score 9 (± 1) 9 (± 1) p=0.71
Prior Cesarean Delivery 40.5% (n=188) 44.7% (n=230) p=0.18

















































Continuous data presented as mean values (± standard deviation) or median [Interquartile Range]. Categorical data presented as a 
percentage of the total.





























12 month run-in period
